Personalized Logistics for Cell & Gene Therapies: As the trusted leader in personalized medicine logistics and transportation, Quick provides customized solutions and protocols to ensure the safety and integrity of your Cell and Gene Therapies. Quick’s CGT Center of Excellence delivers logistics expertise, temperature control, chain of custody and quality control processes. Our specially trained global team, with unmatched experience, will help you plan, design and support your logistics operation, so you can focus on your core business – creating cutting-edge treatments.
Invitae is bringing comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. As one of the fastest growing genetic information companies, Invitae is advancing the broad potential of genetics. The company provides genetic information services for all stages of life – from preconception screening, to newborn diagnosis, to inherited disease screening, to proactive health management – and a unique, rapidly expanding network of patients, hospital systems, and advocacy partners that is moving genetics from one-dimensional testing to complex information management. www.invitae.com
Scientist.com is on a mission to empower and connect researchers worldwide through our online B2B marketplace with a faster, leaner and “innovation-centric” approach to the sourcing of custom scientific services. Founded in 2007, Scientist.com is the pioneer and industry leader in this space. Scientist.com has multiyear partnerships with most of the world’s major pharmaceutical companies, VWR International and the NIH.
Brammer Bio is a CDMO focused on providing process development, clinical, and commercial supply of cell and gene therapy products, enabling the delivery of novel medicines and improving patient health. We have a highly skilled team with the development, manufacturing, analytical, and operational expertise from over 100 client projects that is required to tackle the challenges posed by these novel technologies… Read More
Rho, a contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 30 years, Rho has been a trusted partner to leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.
Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic proteins, and other complex biologics.
Vigene Biosciences’ mission is to Make Gene Therapy Affordable. Headquartered in Rockville, MD, Vigene offers FDA and EMA compliant cGMP production for AAV, lentivirus, adenovirus. With a proven record of cGMP grade AAV, lentivirus and adenovirus production, Vigene is combining the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical material clients. [Read More]
We want to be your partner and drive pioneering therapies to the market. We invest in enabling technologies and build expertise to support the development and commercialization of your new innovative therapy. Our scientists and engineers bring decade-long development experience across a broad spectrum of cell types and technologies. This builds the backbone of an extensive service offering… Read More
Diamond Pharma Services is a leading European technical and scientific consulting group with deep expertise in gene therapies. Diamond are proud to have supported the regulatory approval of the first gene therapy product in Europe (Glybera), and continue to work on a broad portfolio of gene, and gene modified cell therapies.
Our specialised team has broad and varied industry experience offering both breadth and depth of expertise, from which our clients can benefit. Diamond offers a comprehensive service including regulatory affairs, product development (non-clinical, CMC and clinical), pharmacovigilance and quality & compliance.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities… Read More